Breaking News
Get 40% Off 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks
Close

XORTX Therapeutics Inc (XRTX)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow XORTX Therapeutics's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
3.0000 +0.4100    +15.83%
26/04 - Closed. Currency in USD ( Disclaimer )
After Hours
2.8600
-0.1400
-4.6667%
0:35:25 - Real-time Data
  • Volume: 25,019
  • Bid/Ask: 2.8000 / 3.0000
  • Day's Range: 2.5301 - 3.0000
Type:  Equity
Market:  United States
XORTX Therapeutics 3.0000 +0.4100 +15.83%

XORTX Therapeutics Company Profile

 
Read the XORTX Therapeutics Inc company profile to learn more about the business and the management team. View XORTX Therapeutics Inc facts about employee data, company products and services, and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

3

XORTX Therapeutics Inc., a late stage clinical pharmaceutical company, engages in the development and commercialization of therapies to treat progressive kidney diseases, diabetes, insulin resistance, metabolic syndrome, diabetes, diabetic nephropathy, and infection. It develops XRx-008, a late clinical stage program therapy for autosomal dominant polycystic kidney disease; XRx-101, an uric acid lowering agent used to treat patients infected with the coronavirus COVID-19 infection and acute kidney injury (AKI) associated health consequences; and XRX-225, a program for treatment of type 2 diabetic nephropathy. The company has a collaboration and license agreements with the Icahn School of Medicine to study the incidence of AKI and hyperuricemia in patients hospitalized with COVID-19; and with the University of Florida Research Foundation, Inc. XORTX Therapeutics Inc. is based in Alberta Beach, Canada.

Contact Information

Address 3710 – 33rd Street NW
Alberta Beach, T2L 2M1
Canada
Phone 403 455 7727
Fax -

Top Executives

Name Age Since Title
Raymond Pratt - 2021 Independent Director
Allen Warren Davidoff 63 2018 Founder, CEO, President & Director
Anthony J. Giovinazzo 66 2022 Independent Chair of the Board
Paul Joseph Van Damme 73 2018 Independent Director
Richard J. Johnson - - Member of Clinical Advisory Board
Henk E. D. J. ter Keurs - - Member of Scientific Advisory Board
Anjay Rastogi - 2020 Member of the Clinical Advisory Board
Federico Maese - 2018 Member of Clinical Advisory Board
Charles Edelstein - 2021 Member of the Advisory Board
Petter Bjornstad - 2018 Member of Clinical Advisory Board
William J. Farley 70 2021 Independent Director
Patrick A. Treanor 56 2023 Director
Raymond Dennis Pratt 73 2021 Independent Director
Ronald Perrone - 2024 Member of Clinical Advisory Board
Abigail L. Jenkins 48 2024 Director
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

XRTX Price Commentary

Write your thoughts about XORTX Therapeutics Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email